$UUU
UNIVERSAL SECURITY INSTRUMENTS INC

2014 Q3 Form 10-Q Financial Statement

#000114420414069628 Filed on November 19, 2014

View on sec.gov

Income Statement

Concept 2014 Q3 2013 Q3
Revenue $2.224M $3.196M
YoY Change -30.41% -7.56%
Cost Of Revenue $1.730M $2.390M
YoY Change -27.62% 4.82%
Gross Profit $493.5K $809.2K
YoY Change -39.01% -31.04%
Gross Profit Margin 22.19% 25.32%
Selling, General & Admin $1.119M $1.032M
YoY Change 8.48% -16.99%
% of Gross Profit 226.79% 127.51%
Research & Development $260.0K $94.51K
YoY Change 175.09% -23.51%
% of Gross Profit 52.68% 11.68%
Depreciation & Amortization $10.00K $10.00K
YoY Change 0.0% 0.0%
% of Gross Profit 2.03% 1.24%
Operating Expenses $1.379M $1.126M
YoY Change 22.46% -17.58%
Operating Profit -$885.7K -$317.1K
YoY Change 179.32% 64.19%
Interest Expense -$230.0K $240.0K
YoY Change -195.83% -400.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $9.348K -$79.32K
YoY Change -111.79% -60.34%
Income Tax $0.00 $2.480M
% Of Pretax Income 0.0%
Net Earnings -$1.112M -$2.559M
YoY Change -56.54% 1072.91%
Net Earnings / Revenue -50.01% -80.09%
Basic Earnings Per Share -$0.48 -$1.12
Diluted Earnings Per Share -$0.48 -$1.12
COMMON SHARES
Basic Shares Outstanding 2.313M shares 2.288M shares
Diluted Shares Outstanding 2.313M shares 2.288M shares

Balance Sheet

Concept 2014 Q3 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.790M $1.020M
YoY Change 173.53% -19.69%
Cash & Equivalents $2.789M $1.017M
Short-Term Investments
Other Short-Term Assets $380.0K $360.0K
YoY Change 5.56% -33.33%
Inventory $2.842M $6.044M
Prepaid Expenses $382.1K $361.8K
Receivables $298.3K $189.9K
Other Receivables $1.190M $1.600M
Total Short-Term Assets $7.633M $9.703M
YoY Change -21.33% -10.32%
LONG-TERM ASSETS
Property, Plant & Equipment $120.0K $134.1K
YoY Change -10.53% -16.18%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $13.92M $15.01M
YoY Change -7.26% 16.36%
Other Assets $40.00K $38.13K
YoY Change 4.89% -98.52%
Total Long-Term Assets $14.16M $15.26M
YoY Change -7.24% -2.86%
TOTAL ASSETS
Total Short-Term Assets $7.633M $9.703M
Total Long-Term Assets $14.16M $15.26M
Total Assets $21.79M $24.96M
YoY Change -12.71% -5.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $780.0K $315.2K
YoY Change 147.46% -59.07%
Accrued Expenses $290.0K $160.0K
YoY Change 81.25% 6.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.070M $582.3K
YoY Change 83.76% -36.71%
LONG-TERM LIABILITIES
Long-Term Debt $25.00K $25.00K
YoY Change 0.0%
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $25.00K $25.00K
YoY Change 0.0% -16.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.070M $582.3K
Total Long-Term Liabilities $25.00K $25.00K
Total Liabilities $1.100M $607.3K
YoY Change 81.13% -35.39%
SHAREHOLDERS EQUITY
Retained Earnings $10.31M
YoY Change
Common Stock $12.82M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $20.85M $24.36M
YoY Change
Total Liabilities & Shareholders Equity $21.95M $24.96M
YoY Change -12.06% -5.92%

Cashflow Statement

Concept 2014 Q3 2013 Q3
OPERATING ACTIVITIES
Net Income -$1.112M -$2.559M
YoY Change -56.54% 1072.91%
Depreciation, Depletion And Amortization $10.00K $10.00K
YoY Change 0.0% 0.0%
Cash From Operating Activities -$170.0K -$730.0K
YoY Change -76.71% -51.97%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $260.0K
YoY Change -100.0% 333.33%
Cash From Investing Activities $0.00 $260.0K
YoY Change -100.0% 333.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -170.0K -730.0K
Cash From Investing Activities 0.000 260.0K
Cash From Financing Activities 0.000
Net Change In Cash -170.0K -470.0K
YoY Change -63.83% -69.48%
FREE CASH FLOW
Cash From Operating Activities -$170.0K -$730.0K
Capital Expenditures $0.00 $0.00
Free Cash Flow -$170.0K -$730.0K
YoY Change -76.71% -51.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
4738328 USD
CY2014Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
298338 USD
CY2014Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
406012 USD
us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
12762882 USD
us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
8520500 USD
us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
3681014 USD
us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
1841037 USD
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
1165070 USD
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
-494854 USD
CY2013Q3 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
15019984 USD
CY2014Q3 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
17222188 USD
CY2013Q3 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
35206745 USD
CY2014Q3 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
34811711 USD
CY2013Q3 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
4925122 USD
CY2014Q3 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
7084981 USD
uuu Increase Or Decrease In Inter Company Profit In Inventory
IncreaseOrDecreaseInInterCompanyProfitInInventory
145041 USD
uuu Increase Or Decrease In Inter Company Profit In Inventory
IncreaseOrDecreaseInInterCompanyProfitInInventory
165799 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2050993 USD
CY2014Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
686228 USD
CY2014Q1 us-gaap Other Receivables
OtherReceivables
67583 USD
CY2014Q1 us-gaap Due From Joint Ventures Current
DueFromJointVenturesCurrent
137360 USD
CY2014Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
891171 USD
CY2014Q1 us-gaap Assets Current
AssetsCurrent
8940340 USD
CY2014Q1 uuu Due From Factor
DueFromFactor
1397951 USD
CY2014Q1 us-gaap Inventory Net
InventoryNet
4194213 USD
CY2014Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
25000 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2788927 USD
CY2014Q3 us-gaap Other Receivables
OtherReceivables
65244 USD
CY2014Q3 us-gaap Due From Joint Ventures Current
DueFromJointVenturesCurrent
134253 USD
CY2014Q3 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
497835 USD
CY2014Q3 uuu Due From Factor
DueFromFactor
1122482 USD
CY2014Q3 us-gaap Inventory Net
InventoryNet
2841982 USD
CY2014Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
382137 USD
CY2014Q3 us-gaap Assets Current
AssetsCurrent
7633363 USD
CY2014Q3 us-gaap Accounts Payable Related Parties Current And Noncurrent
AccountsPayableRelatedPartiesCurrentAndNoncurrent
0 USD
CY2014Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
210540 USD
CY2013Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
57000 USD
CY2009Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
25000 shares
CY2009Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.25
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
44468 USD
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2312887 shares
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2312887 shares
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2312887 shares
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2312887 shares
CY2014Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2223943 USD
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3195611 USD
CY2014Q1 us-gaap Accounts Payable Related Parties Current And Noncurrent
AccountsPayableRelatedPartiesCurrentAndNoncurrent
28681 USD
CY2014Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
72512 USD
CY2014Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
23129 USD
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1190128 USD
CY2014Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
12885841 USD
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
8435116 USD
CY2014Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
57000 USD
CY2014Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1207818 USD
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
20854843 USD
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21950388 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-954212 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
6201280 USD
uuu Cost Of Goods Sold Acquired From Joint Venture
CostOfGoodsSoldAcquiredFromJointVenture
4132093 USD
uuu Cost Of Goods Sold Acquired From Joint Venture
CostOfGoodsSoldAcquiredFromJointVenture
3312147 USD
CY2013Q3 uuu Cost Of Goods Sold Acquired From Joint Venture
CostOfGoodsSoldAcquiredFromJointVenture
1974681 USD
CY2014Q3 uuu Cost Of Goods Sold Acquired From Joint Venture
CostOfGoodsSoldAcquiredFromJointVenture
1601148 USD
uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
510708 USD
uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
321177 USD
CY2013Q3 uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
411775 USD
CY2014Q3 uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
129279 USD
us-gaap Gross Profit
GrossProfit
1558479 USD
us-gaap Gross Profit
GrossProfit
1105004 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
809155 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
493516 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
221144 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
421946 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
94508 USD
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
259982 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2121490 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2306735 USD
CY2013Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1031746 USD
CY2014Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1119244 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-784155 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1623677 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-317099 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-885710 USD
us-gaap Interest And Other Income
InterestAndOtherIncome
11822 USD
us-gaap Interest And Other Income
InterestAndOtherIncome
16993 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2312887 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2287887 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2312887 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2287887 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2312887 shares
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.12
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.73
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.12
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2287887 shares
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-311696 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-876362 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
504420 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-90377 USD
CY2013Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
232379 USD
CY2014Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-77850 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-267913 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1697061 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-79317 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-954212 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2310835 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2479901 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Net Income Loss
NetIncomeLoss
-2578748 USD
us-gaap Net Income Loss
NetIncomeLoss
-1697061 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-2559218 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.73
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2287887 shares
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2312887 shares
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-15330 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-20396 USD
CY2013Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-8485 USD
CY2014Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
6312 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-127742 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
38086 USD
CY2013Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
46353 USD
CY2014Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-27490 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2721820 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1679371 USD
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2521350 USD
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-975390 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-2310835 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
0 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20319 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23472 USD
us-gaap Share Based Compensation
ShareBasedCompensation
44468 USD
us-gaap Share Based Compensation
ShareBasedCompensation
0 USD
uuu Increase Decrease In Accounts Receivable And Due From Factor
IncreaseDecreaseInAccountsReceivableAndDueFromFactor
-639170 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-21178 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1017402 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Interest Paid
InterestPaid
0 USD
uuu Increase Decrease In Accounts Receivable And Due From Factor
IncreaseDecreaseInAccountsReceivableAndDueFromFactor
-668805 USD
uuu Increase Decrease Ininventories Andprepaid Expenses
IncreaseDecreaseIninventoriesAndprepaidExpenses
1465059 USD
uuu Increase Decrease Ininventories Andprepaid Expenses
IncreaseDecreaseIninventoriesAndprepaidExpenses
-1367357 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-145693 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
284984 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1679128 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
737934 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
257638 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
0 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2438892 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
17690 USD
CY2014Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2311000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
uuu Proceeds From Cash Distributions From Joint Venture
ProceedsFromCashDistributionsFromJointVenture
257638 USD
uuu Proceeds From Cash Distributions From Joint Venture
ProceedsFromCashDistributionsFromJointVenture
0 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1421490 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
737934 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Registrant Name
EntityRegistrantName
UNIVERSAL SECURITY INSTRUMENTS INC
dei Entity Central Index Key
EntityCentralIndexKey
0000102109
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Trading Symbol
TradingSymbol
UUU
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2312887 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2013Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2014Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares

Files In Submission

Name View Source Status
0001144204-14-069628-index-headers.html Edgar Link pending
0001144204-14-069628-index.html Edgar Link pending
0001144204-14-069628.txt Edgar Link pending
0001144204-14-069628-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tlogo.jpg Edgar Link pending
uuu-20140930.xml Edgar Link completed
uuu-20140930.xsd Edgar Link pending
uuu-20140930_cal.xml Edgar Link unprocessable
uuu-20140930_def.xml Edgar Link unprocessable
uuu-20140930_lab.xml Edgar Link unprocessable
uuu-20140930_pre.xml Edgar Link unprocessable
v393534_10q.htm Edgar Link pending
v393534_ex31-1.htm Edgar Link pending
v393534_ex31-2.htm Edgar Link pending
v393534_ex32-1.htm Edgar Link pending
v393534_ex99-1.htm Edgar Link pending